These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 24532547)

  • 1. No evidence of nitrate tolerance caused by nebivolol.
    Stoschitzky K; Stoschitzky G; Pieske B; Wascher T
    Ther Adv Cardiovasc Dis; 2014 Apr; 8(2):40-4. PubMed ID: 24532547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Digital plethysmography and arginine metabolism in prehypertension: effect of nebivolol therapy.
    Kandavar R; Fernandez C; Sander GE; Kim C; Velaga S; Sukhanov S; Delafontaine P; Egan P; Roffidal LE; Giles TD
    J Clin Hypertens (Greenwich); 2015 Jan; 17(1):14-9. PubMed ID: 25495953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasodilators, blood pressure-lowering medications, and age-related macular degeneration: the Beaver Dam Eye Study.
    Klein R; Myers CE; Klein BE
    Ophthalmology; 2014 Aug; 121(8):1604-11. PubMed ID: 24793737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insight into oseophageal injury and protection in physiologically relevant animal models.
    Zayachkivska O; Pshyk-Titko I; Hrycevych N; Savytska M
    J Physiol Pharmacol; 2014 Apr; 65(2):295-307. PubMed ID: 24781738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beneficial effects of nebivolol in comparison with atenolol on safety and tolerability in essential hypertension.
    Bhosale VV; Inamdar SC; V B K; S R B; M B M; A G
    J Clin Diagn Res; 2014 Jun; 8(6):HC01-4. PubMed ID: 25120998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary headache in yemen: prevalence and common medications used.
    Abdo SA; Amood Al-Kamarany M; Alzoubi KH; Al-Maktari MT; Al-Baidani AH
    Neurol Res Int; 2014; 2014():808126. PubMed ID: 25538854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A constrained heart: a case of sudden onset unrelenting chest pain.
    Wilson SR; Kronzon I; Machnicki SC; Ruiz CE
    Circulation; 2014 Oct; 130(18):1625-31. PubMed ID: 25462822
    [No Abstract]   [Full Text] [Related]  

  • 8. Nebivolol, but not metoprolol, lowers blood pressure in nitric oxide-sensitive human hypertension.
    Okamoto LE; Gamboa A; Shibao CA; Arnold AC; Choi L; Black BK; Raj SR; Robertson D; Biaggioni I
    Hypertension; 2014 Dec; 64(6):1241-7. PubMed ID: 25267802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial.
    Montero-Perez-Barquero M; Flather M; Roughton M; Coats A; Böhm M; Van Veldhuisen DJ; Babalis D; Solal AC; Manzano L
    Eur J Heart Fail; 2014 Sep; 16(9):1009-15. PubMed ID: 25044535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nebivolol versus metoprolol on sodium sensitivity and renal sodium handling in hypertensive Hispanic postmenopausal women.
    Preston RA; Afshartous D; Materson BJ; Rodco R; Alonso AB
    Hypertension; 2014 Aug; 64(2):287-95. PubMed ID: 24842917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in bacterial species and antibiotic sensitivity in intensive care unit: acquired urinary tract infection during 10 years interval (2001-2011).
    Yoon BI; Kim HS; Kim SD; Cho KJ; Kim SW; Ha US; Cho YH; Sohn DW
    Urol J; 2014 May; 11(2):1478-84. PubMed ID: 24807764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial.
    Jeger RV; Farah A; Ohlow MA; Mangner N; Möbius-Winkler S; Weilenmann D; Wöhrle J; Stachel G; Markovic S; Leibundgut G; Rickenbacher P; Osswald S; Cattaneo M; Gilgen N; Kaiser C; Scheller B;
    Lancet; 2020 Nov; 396(10261):1504-1510. PubMed ID: 33091360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial.
    Armstrong PW; Lam CSP; Anstrom KJ; Ezekowitz J; Hernandez AF; O'Connor CM; Pieske B; Ponikowski P; Shah SJ; Solomon SD; Voors AA; She L; Vlajnic V; Carvalho F; Bamber L; Blaustein RO; Roessig L; Butler J;
    JAMA; 2020 Oct; 324(15):1512-1521. PubMed ID: 33079152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
    Armstrong PW; Pieske B; Anstrom KJ; Ezekowitz J; Hernandez AF; Butler J; Lam CSP; Ponikowski P; Voors AA; Jia G; McNulty SE; Patel MJ; Roessig L; Koglin J; O'Connor CM;
    N Engl J Med; 2020 May; 382(20):1883-1893. PubMed ID: 32222134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan.
    Selvaraj S; Claggett BL; Böhm M; Anker SD; Vaduganathan M; Zannad F; Pieske B; Lam CSP; Anand IS; Shi VC; Lefkowitz MP; McMurray JJV; Solomon SD
    J Am Coll Cardiol; 2020 Apr; 75(14):1644-1656. PubMed ID: 32192799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline features of the VICTORIA (Vericiguat Global Study in Subjects with Heart Failure with Reduced Ejection Fraction) trial.
    Pieske B; Patel MJ; Westerhout CM; Anstrom KJ; Butler J; Ezekowitz J; Hernandez AF; Koglin J; Lam CSP; Ponikowski P; Roessig L; Voors AA; O'Connor CM; Armstrong PW;
    Eur J Heart Fail; 2019 Dec; 21(12):1596-1604. PubMed ID: 31820546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left ventricular clefts - incidental finding or pathologic sign of Wilson's disease?
    Zhang K; Reuner U; Weidauer M; Speiser U; Ibrahim K; Christoph M; Heinzel FR; Pieske B; Heidrich FM; Quick S
    Orphanet J Rare Dis; 2019 Nov; 14(1):244. PubMed ID: 31699127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of mortality benefit based on periodic repolarisation dynamics in patients undergoing prophylactic implantation of a defibrillator: a prospective, controlled, multicentre cohort study.
    Bauer A; Klemm M; Rizas KD; Hamm W; von Stülpnagel L; Dommasch M; Steger A; Lubinski A; Flevari P; Harden M; Friede T; Kääb S; Merkely B; Sticherling C; Willems R; Huikuri H; Malik M; Schmidt G; Zabel M;
    Lancet; 2019 Oct; 394(10206):1344-1351. PubMed ID: 31488371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of comprehensive initial training on the variability of left ventricular measures using fast-SENC cardiac magnetic resonance imaging.
    Lapinskas T; Hireche-Chikaoui H; Zieschang V; Erley J; Stehning C; Gebker R; Giusca S; Korosoglou G; Zaliunas R; Backhaus SJ; Schuster A; Pieske B; Kelle S
    Sci Rep; 2019 Aug; 9(1):12223. PubMed ID: 31434950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Serelaxin in Patients with Acute Heart Failure.
    Metra M; Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Pang PS; Ponikowski P; Voors AA; Adams KF; Anker SD; Arias-Mendoza A; Avendaño P; Bacal F; Böhm M; Bortman G; Cleland JGF; Cohen-Solal A; Crespo-Leiro MG; Dorobantu M; Echeverría LE; Ferrari R; Goland S; Goncalvesová E; Goudev A; Køber L; Lema-Osores J; Levy PD; McDonald K; Manga P; Merkely B; Mueller C; Pieske B; Silva-Cardoso J; Špinar J; Squire I; Stępińska J; Van Mieghem W; von Lewinski D; Wikström G; Yilmaz MB; Hagner N; Holbro T; Hua TA; Sabarwal SV; Severin T; Szecsödy P; Gimpelewicz C;
    N Engl J Med; 2019 Aug; 381(8):716-726. PubMed ID: 31433919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.